Brett Shandler is an associate in the IP litigation team at Kirkland & Ellis.

Having a background in biomedical sciences, Brett acts in patent litigation and life science regulatory matters involving pharmaceuticals, biologics, genetic technologies and medical devices.

Brett also acts in high-tech matters, and has a particular interest in IP and antitrust issues arising in the context of SEP licensing and FRAND royalty disputes.

Brett has experience acting in multi-jurisdictional patent disputes involving cross-border co-ordination, and in complex damages enquiries.

He has acted in patent matters conducted in the Australian Patent Office, Federal Court of Australia, Full Federal Court of Australia, and High Court of Australia, and has also assisted in an ITC section 337 proceeding.

In 2017 and 2018, Brett was recognised by Lawyers Weekly Australia as one of the top intellectual property lawyers under the age of thirty.

Prior to joining Kirkland & Ellis, Brett was an intellectual property and life science regulatory lawyer at global firm DLA Piper. 


Thought Leadership


“The Hon. Randall R. Rader on ‘The Future of the Patent System’”, AIPPI e-news, 2017

“Australian Federal Court Prevents Registration of the Word ‘Yellow’ As Trade Mark”, The IPKat, 2016

“The patentability of diagnostic methods”, Australasian Biotechnology, Vol 26(3), 2016. (co-author)

Memberships & Affiliations

International Association for the Protection of Intellectual Property (AIPPI)

Law Society of New South Wales (Australia)


Admissions & Qualifications

  • 2016High Court of Australia
  • 2016Supreme Court of Victoria


  • English
  • Hebrew


  • University of MelbourneLL.M.2019
  • University of MelbourneJ.D.2016
  • Georgetown University Law Center, Center for Transnational Legal Studies, LondonTransnational Legal Studies2015
  • Monash UniversityBachelor of Biomedical Science2012